RHOA and lung carcinoma: It has been reported that RAC1 or RhoA are mutated in cancers, and the expression levels of RAC1 or RhoA are aslo altered, which means that RhoA may play an crucial role in lung cancer treatment (Haga and Ridley, 2016).